Current Report Filing (8-k)

Date : 09/11/2019 @ 6:50PM
Source : Edgar (US Regulatory)
Stock : Pharmagreen Biotech Inc. (PHBI)
Quote : 0.49505  -0.01505 (-2.95%) @ 9:04PM

Current Report Filing (8-k)



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

September 3, 2019

Pharmagreen Biotech Inc.

(Exact name of registrant as specified in its charter)

Nevada

333-151350

26-1679929

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)


2987 Blackbear Court, Coquitlam, British Columbia

V4E 3A2

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code

702-803-9404

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under

Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares

PHBI

OTC Markets

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



{W0383283}



2



ITEM 1.01

Entry into a Material Definitive Agreement

ITEM 3.02

Unregistered Sales Of Equity Securities.

On September 3, 2019 Pharmagreen Biotech Inc. (“we”, “us”, “our”, the “Company”) entered into a consulting agreement with Emerging Markets Consulting, LLC (“EMC”) pursuant to which we have engaged EMC for a term of 18 months to provide corporate communications, marketing, and related public relations services.


In consideration for EMC’s services we have agreed to issue to EMC 75,000 of our common shares at the beginning of the term, and an additional 75,000 common shares 9 months following the beginning of the term.


Either party may terminate the agreement without notice in the event of bankruptcy, insolvency, receivership, or non-performance by the other.  The Company may also terminate the agreement without cause by providing not less than 30 days’ notice, provided that any payments due prior to the effective date of termination shall remain payable.   


The above issuances of shares to EMC is made to one accredited investor (as that term is defined in Regulation D of the Securities Act of 1933) relying on Rule 506 of Regulation D and/or Section 4(2) of the Securities Act of 1933.



Item 9.01

Financial Statements and Exhibits.

10.1

Agreement dated September 3, 2019 with Emerging Markets Consulting, LLC



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


PHARMAGREEN BIOTECH INC.


/s/ Peter Wojcik

Peter Wojcik

President and Chief Executive Officer

Date:    

September 11, 2019

 

 




{W0383283}


Pharmagreen Biotech Inc. (USOTC:PHBI)
Historical Stock Chart

1 Year : From Jan 2019 to Jan 2020

Click Here for more Pharmagreen Biotech Inc. Charts.

Pharmagreen Biotech Inc. (USOTC:PHBI)
Intraday Stock Chart

Today : Monday 20 January 2020

Click Here for more Pharmagreen Biotech Inc. Charts.

Latest PHBI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.